Literature DB >> 3919662

Hypogammaglobulinaemia associated with gold therapy.

T Hunter.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3919662      PMCID： PMC1001610          DOI： 10.1136/ard.44.3.212-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  Hypogammaglobulinaemia associated with gold therapy.

Authors:  A K So; S A Peskett; A D Webster
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103
  1 in total
  4 in total

1.  Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.

Authors:  M Farr; E Tunn; P A Bacon; D H Smith
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

2.  Antibody deficiency associated with gold treatment: natural history and management in 22 patients.

Authors:  N Snowden; D M Dietch; L S Teh; R C Hilton; M R Haeney
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

3.  Evaluation of the skin-sensitizing potential of gold nanoparticles and the impact of established dermal sensitivity on the pulmonary immune response to various forms of gold.

Authors:  K A Roach; S E Anderson; A B Stefaniak; H L Shane; G R Boyce; J R Roberts
Journal:  Nanotoxicology       Date:  2020-09-10       Impact factor: 5.913

4.  Adult acquired combined immune deficiency in a patient with rheumatoid arthritis on gold.

Authors:  D O Haskard; D Macfarlane
Journal:  J R Soc Med       Date:  1988-09       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.